[1]王 婷,韦小碗,杨 亮,等.脓毒症患者血清PCT、CRP、IL-6 和IL-10水平检测及临床意义[J].陕西医学杂志,2020,49(11):1510-1514.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.037]
　WANG Ting,WEI Xiaowan,YANG Liang,et al.Expression of serum PCT,CRP,IL-6 and IL-10 in patients with sepsis and their clinical diagnostic value[J].,2020,49(11):1510-1514.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.037]
点击复制

脓毒症患者血清PCT、CRP、IL-6 和IL-10水平检测及临床意义
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
49
期数:
2020年11期
页码:
1510-1514
栏目:
临床检验
出版日期:
2020-11-05

文章信息/Info

Title:
Expression of serum PCT,CRP,IL-6 and IL-10 in patients with sepsis and their clinical diagnostic value
作者:
王 婷1; 韦小碗1; 杨 亮1; 邹远妩2△; 梁亚萍2; 王 卓2
1.陕西省安康市中心医院(安康725000); 2.陕西省结核病防治院(陕西省第五人民医院)(西安710100)
Author(s):
WANG Ting; WEI Xiaowan; YANG Liang; et al.
Ankang Center Hospital,Shaanxi Province(Ankang 725000)
关键词:
脓毒症;  诊断;  降钙素原;  C反应蛋白;  白细胞介素-6;  白细胞介素-10
Keywords:
Sepsis;  Diagnosis;  Procalcitonin;  C reactive protein;  Interleukin-6;  Interleukin-10
分类号:
R631
DOI:
DOI:10.3969/j.issn.1000-7377.2020.11.037
文献标志码:
A
摘要:
目的:探讨脓毒症患者血清中降钙素原(PCT),C反应蛋白(CRP),白细胞介素-6(IL-6),白细胞介素-10(IL-10)的表达水平及临床诊断价值。方法:选取40例脓毒症患者作为脓毒症组,同期40例非感染性全身炎症反应综合征(SIRS)患者作为非脓毒症组; 另选取同期40例健康体检者作为正常对照组; 根据28 d后是否存活将脓毒症组分为存活组(n=24)和死亡组(n=16)。分析比较各组入院24 h内PCT、CRP、IL-6、IL-10的水平,并绘制工作特征曲线(ROC曲线)分析上述指标对脓毒症的诊断价值。结果:脓毒症组血清中PCT、CRP、IL-6、IL-10水平均显著均高于非脓毒症组和正常对照组(均P<0.01)。脓毒症组40例研究对象中死亡16(40.00%)例,死亡组血清中PCT、CRP、IL-6 及IL-10水平均显著高于存活组,差异有统计学意义(t=3.23,P<0.01; t=2.26,P=0.03; t=2.39,P=0.02; t=2.19,P<0.05); ROC分析结果显示:PCT的诊断曲线下面积(AUC)最大为0.84,灵敏度为87.50%,特异度为81.25%,最佳临界值为1.13 ng/ml; CRP的 AUC为0.76,灵敏度为75.00%,特异度为86.25%,最佳临界值为63.95 mg/ml; IL-6的AUC为0.80,灵敏度为72.50%,特异度为88.75%,最佳临界值为105.20 pg/ml; IL-10的 AUC为0.76,灵敏度为82.50%,特异度为80.00%,最佳临界值为84.13 mg/ml。结论:血清PCT、CRP、IL-6及IL-10水平在在脓毒症患者中明显升高,并与脓毒症患者的预后有一定的相关性; PCT的灵敏性优于CRP、IL-6及IL-10,IL-6的特异性优于其他指标,因此,PCT、CRP、IL-6及IL-10对脓毒症早期诊断均有一定的价值。
Abstract:
Objective:To investigate the expression of procalcitonin(PCT),C reactive protein(CRP),interleukin-6(IL-6)and interleukin-10(IL-10)in serum of patients with sepsis and their clinical diagnostic value.Methods:40 patients with sepsis were selected as the sepsis group,40 patients with noninfective SIRS during the same period were selected as the non sepsis group,another 40 healthy people during the same period were selected as the normal control group.The sepsis group was divided into survival group(n=24)and death group(n=16)according to whether they survived 28 days later.The levels of PCT,CRP,IL-6 and IL-10 within 24 hours after admission were analyzed and compared,and the ROC curve was drawn to analyze the diagnostic value of the above indexes for sepsis.Results:The serum levels of PCT,CRP,IL-6 and IL-10 in sepsis group were significantly higher than those in non sepsis group and normal control group(P<0.01).In sepsis group,16 of 40 subjects died and the levels of PCT,CRP,IL-6 and IL-10 of death group were higher than those of survival group(P<0.05).The results of ROC analysis showed that the AUC of PCT was 0.84,the sensitivity was 87.50%,the specificity was 81.25%,and the best critical value was 1.13 ng/ml; the AUC of CRP was 0.76,the sensitivity was 75.00%,the specificity was 86.25%,and the best critical value was 63.95 mg/ml; the AUC of IL-6 was 0.80,the sensitivity was 72.50%,the specificity was 88.75%,and the best critical value was 105.20 pg/ml; the AUC of IL-10 was 0.76,the sensitivity was 82.50%,the specificity was 80.00%,and the best critical value was 84.13 mg/ml.Conclusion:The levels of serum PCT,CRP,IL-6 and IL-10 are significantly increased in sepsis patients,and and have a certain correlation with the prognosis of sepsis patients.The sensitivity of PCT is better than CRP,IL-6 and IL-10,and the specificity of IL-6 is better than other indexes.Therefore,PCT,CRP,IL-6 and IL-10 have certain diagnostic value for the early diagnosis of sepsis.

参考文献/References:

[1] Jain S.Sepsis:an update on current practices in diagnosis and management[J].Am J Med Sci,2018,356(3):277-286.
[2] 付 阳,陈 捷,蔡 蓓,等.血清降钙素原和免疫炎性因子C反应蛋白、白介素-6、血清淀粉样蛋白A在脓毒血症中的诊断价值[J].四川大学学报:医学版,2012,43(5):702-705.
[3] 刘蕾蕾,华 玮,居培红,等.脓毒症患者血清中白细胞介素-6和降钙素原表达及其临床意义[J].分子诊断与治疗杂志,2019,11(6):527-530.
[4] Wong DM,Ruby RE,Dembek KA, et al.Evaluation of updated sepsis scoring systems and systemic inflammatory response syndrome criteria and their association with sepsis in equine neonates[J].J Vet Intern Med,2018,32(3):1185-1193.
[5] 高 戈,冯 喆,常志刚,等.2012国际严重脓毒症及脓毒性休克诊疗指南[J].中华危重病急救医学,2013,25(8):501-505.
[6] Gudernatsch V,Stefańczyk SA,Mirakaj V.Novel resolution mediators of severe systemic inflammation[J].Immunotargets Ther,2020,6(9):31-41.
[7] 黄国兰,谢宗贤,裴 杰,等.炎症因子评估脓毒血症患者疾病预后的应用价值[J].现代医学,2019 47(7):778-782.
[8] 计 鹏,胡大海,杨 晨,等.重度烧伤并发脓毒症64例血清TNF-α、IL-1β、IL-6水平测定及其相关性分析[J].陕西医学杂志,2016,45(9):1173-1174.
[9] Naqvi SA,Thompson GC,Joffe AR,et al.Cytokines and chemokines in pediatric appendicitis:a multiplex analysis of inflammatory protein mediators [J].Mediators Inflamm,2019,2019(12):1-13.
[10] Chang JC.Sepsis and septic shock:endothelial molecular pathogenesis associated with vascular microthrombotic disease[J].Thromb J,2019,30(17):10.
[11] 付玉梅,王俊红,张 冲,等.急诊重症多发伤患者合并早期脓毒症血清PCT、IL-6及CRP水平检测的临床价值分析[J].现代诊断与治疗,2019,30(10):1660-1661.
[12] Ettinger M,Calliess T,Kielstein JT,et al.Circulating biomarkers for discrimination between aseptic joint failure,low-grade infection,and high-grade septic failure[J].Clin Infect Dis,2015,61(3):332-341.
[13] Sapan HB,Paturusi I,Jusuf I,et al.Pattern of cytokine(IL-6 and IL-10)level as inflammation and anti-inflammation mediator of multiple organ dysfunction syndrome(MODS)in polytrauma[J].Int J Burns Trauma,2016,6(2):37-43.
[14] Feng M,Sun T,Zhao Y,et al.Detection of serum interleukin-6/10/18 levels in sepsis and its clinical significance[J].J Clin Lab Anal,2016,30(6):1037-1043.
[15] 薄 蔚.血清穿透素-3、白细胞介素-27与降钙素原对脓毒症诊断及预后的价值研究[J].国际检验医学杂志,2019,40(21):2658-2662
[16] Covington EW,Roberts MZ,Dong J.Procalcitonin monitoring as a guide for antimicrobial therapy:a review of current literature[J].Pharmacotherapy,2018,38(5):569-581.
[17] 邢 静,李 锐,张 彧.脓毒症病理生理变化的研究进展[J].中国急救复苏与灾害医学杂志,2009,4(3):175-178.

相似文献/References:

[1]李文军,于代华,宗 雷,等.脾多肽注射液对脓毒症患者血清炎症因子及免疫功能的影响*[J].陕西医学杂志,2019,(4):463.
　LI Wenjun,YU Daihua,ZONG Lei,et al.Effect of spleen peptide injection on serum inflammatory factors and immune function in patients With Sepsis[J].,2019,(11):463.
[2]商跃云,张 慧,林书祥,等.脓毒症患儿外周血CD4+T细胞Bip、ATF6及DDIT3表达水平变化[J].陕西医学杂志,2019,(6):706.
　SHSNG Yueyun,ZHANG Hui,LIN Shuxiang,et al.Changes of immunoglobulin binding protein, activating transcription factor 6 and DNA-damage-inducible transcript 3 protein levels in CD4+T cells in children with sepsis[J].,2019,(11):706.
[3]王双龙,于 美,吕 镔,等.声脉冲辐射力成像定量评估兔肝缺血再灌注损伤实验研究*[J].陕西医学杂志,2020,49(2):140.
　WANG Shuanglong,YU Mei,LV Bin,et al.Quantitative assessment of hepatic ischemia reperfusion injury with acoustic radiation force impulse in rabbit[J].,2020,49(11):140.
[4]陈 爽.不同彩色多普勒超声检查方式在异位妊娠早期诊断中的应用研究[J].陕西医学杂志,2020,49(2):154.
　CHEN Shuang..Application of different color Doppler ultrasonography in early diagnosis of ectopic pregnancy[J].,2020,49(11):154.
[5]刘永收,张 媛,秦 梅,等.手环血氧仪在阻塞性睡眠呼吸暂停低通气综合征诊断中的应用[J].陕西医学杂志,2020,49(2):176.
　LIU Yongshou,ZHANG Yuan,QIN Mei,et al.Application of wearable reflex oximeter in the diagnosis of obstructive sleep apnea-hypopnea syndrome[J].,2020,49(11):176.
[6]宋亚邛,胡海燕△.VEGF、TGF-β1、CA19-9、CA242和DKK1联合检测对早期胰腺癌临床诊断价值研究*[J].陕西医学杂志,2020,49(2):237.
　SONG Yaqiong,HU Haiyan..Clinical value analysis of combined examination of VEGF,TGF-β1,CA19-9,CA242 and DKK1 in patients with early pancreatic cancer[J].,2020,49(11):237.
[7]郭晓波,蔺 京,来春艳,等.新型冠状病毒与实时荧光RT-PCR核酸检测*[J].陕西医学杂志,2020,49(3):264.
[8]王 琪,卢朝祥△,陈晓峰,等.预测6月龄以下骶尾部畸胎瘤良恶性的列线图建立研究[J].陕西医学杂志,2020,49(3):313.
　WANG Qi,LU Chaoxiang,CHEN Xiaofeng,et al.Establishment of anomogram for predicting benign and malignant sacrococcygeal teratomas below 6 months[J].,2020,49(11):313.
[9]王迎春,孔延亮,蔚文祥,等.家庭聚集性新型冠状病毒肺炎患者初次就诊临床检验与CT特征分析[J].陕西医学杂志,2020,49(4):392.
　WANG Yingchun,KONG Yanliang,WEI Wenxiang,et al.Laboratory examination and CT features of family aggregative corona virus disease 2019 patients at first visit[J].,2020,49(11):392.
[10]田永超.脓毒症肠黏膜屏障功能障碍防治研究进展[J].陕西医学杂志,2020,49(4):510.
　TIAN Yongchao..Progress in prevention and treatment of intestinal mucosal barrier dysfunction in sepsis[J].,2020,49(11):510.

更新日期/Last Update: 2020-11-05